Companies in #Generics

Aurobindo Pharma Limited (NSE: AUROPHARMA; BSE: 524804) is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, New Jersey. Aurobindo develops, manufactures, and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs) across oral solids, injectables, and over-the-counter products, with manufacturing operations in India, the U.S., Brazil, and Portugal. The company is one of the largest generic-ARV (antiretroviral) suppliers globally and is expanding into biosimilars, vaccines, and peptides through its biologics division.

Developer and manufacturer of FDA-approved generic and specialty brand medicines, including Lomaira (phentermine hydrochloride), produced in the United States at its Newtown, Pennsylvania facility.

Sandoz is a global leader in generic pharmaceuticals and biosimilars, spun off from Novartis in 2023 to focus on off-patent medicines across immunology, oncology, infectious diseases, and metabolic disorders.